Practical Blood Bank Blood Transfusion Process Pretransfusion Transfusion Posttransfusion What is compatibility testing Also called pretransfusion testing Purpose To select blood components that will not cause harm to the recipient and will have acceptable survival when transfus ID: 484777
Download Presentation The PPT/PDF document "Compatibility Testing" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Compatibility Testing
Practical
Blood BankSlide2
Blood Transfusion Process Pre-transfusion Transfusion
Post-transfusionSlide3
What is compatibility testing?Also called pretransfusion testingPurpose:
To select blood components that will not cause harm to the recipient and will have acceptable survival when transfused
If properly performed, compatibility tests will confirm ABO compatibility between the component and the recipient and will detect the most clinically significant unexpected antibodiesSlide4
Compatibility testing?There are several components of compatibility testingProper specimen collection
Reviewing patient transfusion historyABO, Rh, and antibody testing (screen/ID)
Crossmatching
Actual transfusionSlide5
Compatibility testingCan be divided into 3 categories:Preanalytical procedures
Serological testingPostanalytical proceduresSlide6
Pre-analytical phasesPatient identificationSpecimen collectionReview of patient historySlide7
Patient IdentificationMust confirm recipient’s ID from bracelet ON the patientFull patient name and hospital numberName of physicianSlide8
Sample IdentificationThe sample should also have the full patient name, hospital number, and physicianDate and time of collection, phlebotomist’s initials
All of this should be on the request form and the sampleSlide9
Specimen Tubes
Pink Top - EDTA
Red Top – no additivesSlide10
Specimen CollectionCollected in tube with EDTA or no additivesIf the venipuncture causes hemolysis, the sample may be rejected
True hemolysis in the patient is the result of complement activationSamples are labeled at the bedside (pre-labeling is not recommended)
A record of individuals who collect (or test) the specimens should be documented in order to “backtrack” in case of an errorSlide11
Specimen CollectionIf the sample is drawn from an IV line, the IV infusion should be stopped 5-10 minutes prior to blood drawing and the first 10 mL discarded
Testing should be performed on samples less than 72 hours
or else complement dependent antibodies may be missed (complement can become unstable)Slide12
Getting the historyLook at recipient’s records for any prior unexpected antibodiesPrevious transfusion reactionsSlide13
Serological Testing3 tests:ABO/RhAntibody detection/identification
Crossmatch Slide14
ABO/Rh TypingIn the ABO typing, the forward and reverse MUST matchIn the Rh typing, the control must be negative
Both of these will indicate what type of blood should be givenSlide15
Antibody screen and/or IDThe antibody screen will detect the presence of any unexpected antibodies in patient serum
If antibodies are detected, identification should be performed using panel cells (with an autocontrol)IS
37° (LISS)
AHG
If an antibody is present, units negative for the antigen must be given
Proceed to the crossmatch…Slide16
CrossmatchingPurpose:Prevent transfusion reactions
Increase in vivo
survival of red cells
Double checks for ABO errors
Another method of detecting antibodiesSlide17
CrossmatchTwo types of crossmatchesMajor – routinely performed in labs
Minor – not required by AABB since 1976Slide18
Major vs Minor CrossmatchWhy is the minor crossmatch unnecessary?Donated units are tested for antibodies
Most blood is transfused as packed cells, having little antibodiesThe plasma volume is small, and Abs will be diluted in recipient circulationSlide19
Crossmatches
The crossmatch “shall use methods that demonstrate ABO incompatibility and clinically significant antibodies to red cell antigens and shall include an antiglobulin phase”Slide20
Crossmatch
Donor RBCs (washed)
Patient serum
No agglutination ~ compatible
Agglutination ~ incompatibleSlide21
The procedureDonor cells are taken from segments
that are attached to the unit itself
Segments are a sampling of the blood and eliminate having to open the actual unitSlide22
Units of whole blood with segments attachedSlide23
ProcedureABO/Rh typing is FIRST performed
Antibody Screen is performed next….Slide24
Crossmatch Procedure If antibodies are
NOT detected:
Only immediate spin (IS) is performed using patient serum and donor blood suspension
This fulfills the AABB standard for ABO incompatibility
This is an
INCOMPLETE CROSSMATCH
If antibodies
ARE
detected:
Antigen negative units found and X-matched
All phases are tested: IS, 37°, AHG
This is a
COMPLETE CROSSMATCHSlide25Slide26
Crossmatches… WillVerify donor cell ABO compatibility
Detect most antibodies against donor cells
Will Not
Garantee normal survival of RBCs
Prevent patient from developing an antibody
Detect all antibodies
Prevent delayed transfusion reactions
Detect ABO/Rh errorsSlide27
Incompatible crossmatches
Antibody screen
Crossmatch
Cause
Resolution
Positive
Negative
Antibody directed against antigen on screening cell
ID antibody, select antigen negative blood
Negative
Positive
Antibody directed against antigen on donor cell which may not be on screening cell
OR
donor unit may have IgG previously attached
ID antibody, select antigen negative blood
OR
perform DAT on donor unit
Positive
Positive
Antibodies directed against both screening and donor cells
Antibody ID, select antigen negative bloodSlide28
Additional Information on Types of Compatibility TestsManual (IS and IAT)
Gel TechnologyElectronic (Computerized) Cross match
Red cell Affinity Column Technology (ReACT)
Solid Phase Adherence Assays (SPAA)Slide29
Manual (IS and IAT)IS detect RT reactive antibodies (Auto, Alloantibody, Naturally occuring)
IAT detect IgG antibodies (Auto & alloantibody)Slide30
Gel TechnologyPatient serum, and 1% of suspended RBCs in LIM are dispensed into the microtube and incubated at 37
oC for 15 minutes.
The card containing the microtubes is then centrifuged at a controlled speed for 10 minutes.
At the start of centrifugation the cells are separated from the serum; then they meet the AHG contained in the microtube.
Finally the cells are trapped by the gel (if agglutinated) or pellet to the bottom of the tube.Slide31
New Technologies…The electronic crossmatchAccording to the AABB, the following must be fulfilled:
Critical elements of the information system have been validated on-site. No clinically significant antibodies are detected in the current blood sample and there is no record of clinically significant antibodies in the pastSlide32
Computer crossmatch (cont’d)The patient's ABO group and Rh type has been done twice and entered in the computer
The donor ABO/Rh have been confirmed and entered in the computer. The donor unit identification number, component name, and ABO/Rh type must also be entered in the computer The computer system will alert the technologist to ABO & Rh discrepancies between information on the donor label and results of donor confirmatory testing Slide33
Red Cell Affinity Column Technology (ReACT)
Based on affinity adherence of coated red cells in an immunologically active matrix.
Antibody- sensitized red cells bind or adsorbed to ligands attached to an agarose matrix.
The main ligand is Protein G (prepared from Group C or G Streptococcus or by recombinant technology), which has high affinity for all four IgG subclasses.
Another ReACT ligand is Protein A (from Group A Staphlococcus), which binds to IgG 1, 2, and 4.Slide34
Red Cell Affinity Column Technology (ReACT)Positive reaction: the coated red blood cells with IgG are bound to immunoreactive gel particles, occurs mostly at the top of the gel column.
Negative reaction: the red blood cells are not coated with antibody and pass through to the bottom of the gel column. Slide35
Solid Phase Adherence Assays (SPAA) Uses red cell membrane bound to the surfaces of polystyrene microtitration strip wells, capturing IgG antibodies (if present) in patient sera.
Patient serum is added to wells coated with screen cells
Incubated at 37
o
C for 15 min.
Washing
anti-IgG-coated indicator red cells are added.
centrifugeSlide36
SPAASlide37
Post-analytical phaseInvolves labeling, inspecting, and issuing the blood unitLabeling form includes patient’s full name, ID number, Location, ABO/Rh(D) of patient and unit, donor #, compatibility results, and tech ID
Form is attached to the donor unit and only released for the recipient
The unit is visually inspected for abnormalities, such as bacterial contamination, clots, etcSlide38
Issuing bloodWhen it’s time to release a blood product to the nurse or physician, a few “checks” must be done
Requisition formComparing requisition form
donor unit tag
blood product label
Name of persons issuing and picking up blood
Date and time of release
Expiration dateSlide39
What if the unit is unused?Blood can be returned to the blood bank if it is not needed for transfusionUnit closure has to remain unopened
Storage temperature must have remained in the required range (1° to 10°C for RBCs)If not at correct temp, unit must be returned within 30 minutes of issueSlide40
Special CircumstancesSlide41
Emergency ReleaseIn an emergency, there may not be enough time to test the recipient’s sampleIn this case, blood is released only when
signed by the physician
(
O negative
)
The tag must indicate it is not
crossmatched
Segments from the released units should be retained for X-matching
Every detail is documented (names, dates..)Slide42
Emergency ReleaseOnce the specimen is received, ABO/Rh typing and antibody screening should be performed
Crossmatching the segments from the released unit should be testedIn addition, the lab may
crossmatch
additional units as a precaution if more blood is needed
If death should occur, testing should be complete enough to show that the death was unrelated to an incompatibilitySlide43
What can be given in an emergency?Group O Rh(D)-negative red cells or AB plasmaEmergency release
Women below or of childbearing ageGroup O Rh(D)-positive red cells
Used as a substitution if O negative is not available
Male or elderly femalesSlide44
Massive transfusionDefined as a transfusion approaching or exceeding the recipient’s own blood volume (about 5 liters or 10-12 units in an adult male) within 24 hour period
The original sample no longer represents the patient’s conditionComplete Crossmatch not necessary (if no antibodies were detected originally)
Give ABO identical units
If antibodies were originally ID’s, continue to give antigen negative unitsSlide45
Donor Selection: Appropriate donor units to give
Patient’s Type
1
st
Choice
Other Choices
O
O
None
A
A
O
B
B
O
AB
AB
A, O, B
only one of the three should be used for a given patient
ABO specific blood should always be given first.
When ABO-specific blood is not available or is in less than adequate supply, alternative blood groups are chosen as summarized in the following table; (
must be administered as red blood cells
). Slide46
Selection of Appropriate Donor Units.Rh-negative blood can be given to Rh-positive patients, however, good inventory management should conserve this limited resource for use in Rh-neg recipients.
If Rh-neg units is near expiration, the unit should be given rather than wasted. Slide47
Selection of Appropriate Donor Units.Rh-pos blood should not be given to Rh(D) -neg women of childbearing age.
Transfusion of
Rh-neg male patients and female patients beyond menopause with Rh-pos blood is acceptable as long as no performed anti-D is demonstrable in the sera
. Slide48
Major Crossmatch TestsIt is done both for IgM and IgG antibodiesRequirement:
Recipient’s serum.Donor’s red cells taken from the tube attached to the bag.Slide49
A-Saline technique
Saline technique is designed to detect compatibility of IgM antibody(ies) in patient’s serum against
antigens
on
donor’s
red
cells
.
Method:
Label 1 tube for each donor sample to be tested.
Put 2 drop of patient’s serum in labeled tube.
Add 1 drop of 2-5% saline suspended red cells of donor
Mix and incubate for 5-10 min. (spin method) or incubate for 30-60 min (sedimentation method) at RT.
Centrifuge at 1000 rpm for 1 min. in spin method (after 5-10 min. incubation);centrifugation is optional in sedimentation method.Slide50
Read the result, observe for hemolysis and agglutination.Negative result should be confirmed under microscope.
Interpretation
Agglutination or hemolysis indicates a positive result (incompatible)
Note: In emergency spin technique is acceptable.
Saline technique is inadequate as a complete compatibility test because it is inadequate to detect clinically significant IgG antibodies.Slide51
B- Anti -Human Globulin Test (IAT)Indirect anti human globulin test (IAT) is the most important and widely used serological procedurein modern blood banking to test the IgG compatibility between recipient’s serum and donor’s cells. The majority of incomplete antibodies are IgG and are detected by AHG test.Slide52
MethodPut 2 drops of patient’s serum in a labeled tube.
Add 1 drop of 2-5 % saline suspended red cells of donor.
Incubate for 30-60 min at 37° C
Centrifuge at 1000 rpm for 1 min, check for hemolysis/agglutination
If there is no hemolysis /agglutination, wash the cells three times with normal saline.Slide53
Perform IAT testAdd 2 drops of polyspecific AHG serum to washed cells
Centrifuge at 1000 rpm for 1 minuteSee for agglutination
Add IgG coated red cells to negative AHG test.
Centrifuge and check for agglutination - if there is no agglutination test is invalid.Slide54
InterpretationHemeolysis or agglutination at any stage indicates incompatibility.Note:
Cross-match can be done by two tubes technique for IgM and IgG separately as described above or by one tubes in which donor’ cell and the patient’s serum after step 5 in saline technique is incubated at 37°C for 20-30 minutes and then do IAT.
In major-cross for IgG antibodies albumin or enzyme or LISS can be used with IAT to increase sensitivity. For techniques see chapter on Antiglobulin Test.Slide55
Cross Match – Major Compatibility Test:
Label 3 tubes S1, S2 (Saline) and A1 (Albumin).To each tube add 2 drops of fresh serum from recipient.
To each Tube add 2 drops of 5% saline suspension of donor's Cells.
To tube A1 add 2 drops of Bovine Albumin (22%).
Centrifuge both tubes S1 and A1 for 15 seconds at 3400 rpm.
Read Macroscopically for Haemolysis and/or agglutination and record results.
ABO incompatibility may be detected in this phase.Slide56
Incubate the Tube S1 at room temperature for 15 min (Optional).Incubate the Tube S2 and A1 in the water bath for 30 min at 37o C.
When the incubation time finished centrifuge the tube/tubes for 15 second at 3400 rpm.
Read the tube/tubes macroscopically for
Haemolysis
and/or agglutination and record results.
Wash Tube A1 with saline 3 times.
Add drops of Anti Human Globulin serum and mix well.
Centrifuge tube A for 15 second at 3400.
Read for agglutination and record the results. Slide57
Interpretation: If no agglutination of Haemolysis is present in corssmatch procedure, the blood is regarded compatible and reported as crossmatch Negative. Slide58
Cross Match – Minor Compatibility Test: Label a test tube with donor number and recipient's initials.
Add one drop of 2-5% suspension Recipient cells.Add 2 drops of Donor serum and 1 drop of 22% bovine albumin to the tube.
Centrifuge immediately 1 min at 1000 rpm.
Read macroscopically for
Haemolysis
and agglutination.
Incubate at 37o C for 30 minutes.
Centrifuge 1 min at 1000 rpm.
Read macroscopically for
Haemolysis
and agglutination.
Wash the tube 3 times with saline.
Add 2 drops of anti human globulin serum to the dry cell button.
Centrifuge 1 min at 1000 rpm.
Read macroscopically for
Haemolysis
and agglutination.
Add
Check Cells to all negative tests; spin, read and record results.Slide59
Interpretation: If no agglutination of Haemolysis is present in corssmatch procedure, the blood is regarded as serological compatible and reported as crossmatch Negative. Slide60
The Incompatible Crossmatch:Although the majority crossmatches will indicates compatibility, problems still occur. Even if an incompatible is detected before crossmatch has been carried to the anti-globin stage, the procedure should be completed for investigational purpose.
If blood is urgently needed, additional donor blood should be crossmatched before starting to investigate the problem.Rather than continuing to crossmatch blindly, it is always advisable to try to determine the
cause of the incompatibility
. However, in emergency situations, it may be necessary to crossmatch many units of blood of appropriate ABO group and Rh Type, in the hope that a compatible unit will be found. In addition,
the patient's blood relatives
should be tested for compatibility since there is an increased chance of finding suitable donors among them.
The antibody should be identified, not only for the present transfusion, but also to protect the patient in any future transfusions when the antibody titer may have decreased or even disappeared.Slide61
The following Questions and Answers will help guide subsequent investigations:
Identification:Is the "Patient's Blood Specimen" really from the intended recipient?
Was a unit of blood with the correct ABO group and Rh Type Selected?
Does both the blood unit pilot tube have the same identification?
ABO grouping:
Recheck recipient and donor from original specimens using freshly prepared red cell suspensions. If anti-A1 or anti-H is identified, blood for transfusion should be selected on the basis of A subgroup.
Rh Type:
Recheck recipient and donor, determination of the Rh phenotype may be helpful in some cases.
Auto Control:
Test Patients serum with his own cells to determine if the problems are due to blood group
isoantibody
, autoantibody, or nonspecific reaction. This control should be run concurrently with
crossmatch
or antibody identification.Slide62
Stage of incompatibility:Procedure will be determined to a large extent by the stage at which the incompatibility is most pronounced, as suggested by the following table.
If some donors are incompatible in an early stage of the
crossmatch
but other donors are not incompatible until a later stage, this might indicate two or more antibodies.
Stage of apparent incompatibility
Possible Cause
Saline or serum at RT
ABO
Error.
Cold
autoagglutinin
or irregular agglutinin
Saline, Serum or High protein at 37
o
C
Irregular Antibody
Autoagglutinin
Rouleaux
Other serum direct Antiglobulin test
Antiglobulin or Enzyme
Irregular Antibody
Autoantibody
Positive Direct Antiglobulin testSlide63
Percentage of incompatible donors:The approximate percentage of incompatible donors may help in elucidate the problem, for example, with an antibody reaction n the Antiglobulin phase: six or seven bloods positive out of 10 bloods tested suggests anti-Fya; one blood positive out of 10 tested suggests anti-K.
Grading donor reactions:
Are the reactions of incompatible bloods all of the same strength? If not
There may be two or more antibodies of varying strength.
The antibody may be exhibiting a
dosage phenomenon
.
What was the patient diagnosis?
Is the direct Antiglobulin test of either recipient or donor positive?
If recipient has a positive direct Antiglobulin tests:
Serum may or may not contain autoantibody. If an autoantibody is present, the serum may react with all donor samples tested. The technique by which the incompatibility is detected depends upon the type of antibody (cold or warm).
All minor
crossmatches
will be incompatible.
If the recipient has been recently transfused, the positive Antiglobulin test may indicate incompatibility of infused donor red cells, specially if the appearance is that of a mixed filed reactionSlide64
If donor has a positive direct Antiglobulin test.Major Crossmatch will be incompatible.Minor crossmatch may or may not be incompatible.Other donor units will crossmatch
satisfactorily.Abnormal proteins,
autoagglutinin
and cold agglutinins
.
Factors relating to disease or medication may cause agglutination or pseudo agglutination.
If
Rouleaux
occurs:
Check patient's diagnosis and serum protein level.
Autologous red cells and serum at 22
o
C and 37
o
C should give the same reactions as in the compatibility test.
Compatibility testing with strong
Rouleaux
, the saline anti-globulin
crossmatch
may be the only reliable test since the Antiglobulin reactions is not affected by properties of serum that cause
Rouleaux
. High protein techniques are affected.Slide65
Cold agglutinins are the most common cause of difficulty in compatibility testing. Although they react best at 4o C, they may cause agglutination in the room temperature phase of the crossmatch and on immediate centrifugation of the high protein test. They also may cause a positive Antiglobulin test, especially in autoimmune disease.Strong cold autoagglutinin, especially those with wide thermal amplitude, must be absorbed from the patient's serum since they may mask the presence of specific blood group antibodies. If the autoantibody is active at 22o C or lower, it can usually be removed from the serum by placing a fresh recipient blood specimen in ice and allowing it to clot in the refrigerator.
After the cold active antibody is adsorbed onto autologous red cell, the absorbed serum is used for antibody detection and compatibility testing. A suspension of the red cells (For Control) should be prepared from blood that has not been refrigerated.Slide66
Does the serum contain irregular antibodies?Test with reagent blood cells (
DiaCell), if this has not been done as part of the compatibility test, identify any antibodies present.If the crossmatch is incompatible only with one donor, and antibody detection tests are negative, the recipient's serum should be tested for antibodies directed against low-incidence
antigens.
Technical
Causes of apparent incompatibility (False Positive):
Dirty Glassware
Bacterial Contamination.
Chemical or other contamination or reagents, including saline.
Fibrin clots.
Over-centrifugation. Slide67
What to Do With Crossmatch CluesSlide68
Crossmatch for Newborns and infants:In case of Erythroblastosis: The corssmatch
should include a crossmatch with the mother's serum. If mother's serum is not available crossmatch with baby's serum.
In ABO incompatibility: choose blood compatible with mother's or group O cells suspended in-group specific plasma. Perform major and minor
crossmatch
.
In Rh incompatibility: Mother and infant are of the same blood group, transfer with compatible group specific Rh Negative
In Rh incompatibility: Mother and infant are of different blood group, choose O Rh Negative cells suspended in-group specific fresh plasma.
In Erythroblastosis due to (c): use blood which is c/c also Rh
o
(D).
In case transfusion is to be repeated, use the same group and method as for the first transfusion
In Case of No Erythroblastosis:
When Infant's RBC is compatible with mother's serum; do
crossmatch
with mother's serum.
When infant's RBC's are incompatible with mother's serum use infant's serum for
crossmatch
.Slide69
Selection of Blood for Exchange transfusion